Computed Tomography and Magnetic Resonance Imaging of Patients With Valvular Heart Disease

2000 ◽  
Vol 15 (4) ◽  
pp. 252-264 ◽  
Author(s):  
Anna Rozenshtein ◽  
Lawrence M. Boxt
Author(s):  
Dominic A. Emerson ◽  
Richard L. Amdur ◽  
Jason R. Morrissette ◽  
Federico E. Mordini ◽  
Christian D. Nagy ◽  
...  

Objective In valvular heart disease, elevated left atrial and pulmonary pressures contribute to right ventricular strain and, ultimately, right ventricle failure. Elevated pulmonary artery (PAP) and left ventricular end diastolic pressures are used as markers of right ventricle dysfunction and correlate with poor outcomes. Using cardiac magnetic resonance imaging (CMR), it is possible to directly quantify both left and right ventricular ejection function (LVEF and RVEF), and here, we compare CMR with traditional markers as outcome predictors. Methods A retrospective review of prospectively collected data was performed for patients from January 2004 to February 2008 at a single center (n = 103). Patients were divided into those receiving CMR (n = 56) and those receiving only catheterization (n = 47). Univariate and multivariate logistic regression models were applied to determine predictors of mortality. Finally, predictive models for mortality using PAP, mean PAP, and left ventricular end diastolic pressure were compared to models using LVEF and RVEF obtained from CMR. Results Preoperative average CMR LVEF and RVEF were 57% and 46%, respectively. Only age emerged as an isolated predictor of mortality ( P = 0.01) within the univariate models. Stepwise regression models were created using the catheterization or CMR data. When compared, the CMR model has a slightly better R2, c (prediction accuracy), and sensitivity/specificity (0.22 vs 0.28, 0.77 vs 0.82, and 0.63/0.62 vs 0.69/0.64, respectively). Conclusions Within our population, LVEF and RVEF predict mortality as least as well as traditional catheterization values. Additionally, CMR may identify of elevated PAPs caused by right ventricle dysfunction and those due to other causes, allowing these other causes to be addressed preoperatively.


2009 ◽  
Vol 29 (4) ◽  
pp. 229-240 ◽  
Author(s):  
Juha W. Koskenvuo ◽  
Vesa Järvinen ◽  
Jussi P. Pärkkä ◽  
Tuomas O. Kiviniemi ◽  
Jaakko J. Hartiala

2019 ◽  
Vol 17 (5) ◽  
pp. 298-312 ◽  
Author(s):  
Pankaj Garg ◽  
Andrew J. Swift ◽  
Liang Zhong ◽  
Carl-Johan Carlhäll ◽  
Tino Ebbers ◽  
...  

AbstractMitral regurgitation (MR) is a common valvular heart disease and is the second most frequent indication for heart valve surgery in Western countries. Echocardiography is the recommended first-line test for the assessment of valvular heart disease, but cardiovascular magnetic resonance imaging (CMR) provides complementary information, especially for assessing MR severity and to plan the timing of intervention. As new CMR techniques for the assessment of MR have arisen, standardizing CMR protocols for research and clinical studies has become important in order to optimize diagnostic utility and support the wider use of CMR for the clinical assessment of MR. In this Consensus Statement, we provide a detailed description of the current evidence on the use of CMR for MR assessment, highlight its current clinical utility, and recommend a standardized CMR protocol and report for MR assessment.


Sign in / Sign up

Export Citation Format

Share Document